NCT03697720View on ClinicalTrials.gov

Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

November 23, 2020

Study Completion Date

September 27, 2023

Conditions

DysmenorrheaPain

Interventions

DRUG

Naproxen

Participants will take naproxen 500mg BID before and for the first 3 days of their period.

Trial Locations (1)

60201

NorthShore University Health System, Evanston

Sponsors

Lead Sponsor

Endeavor Health

All Listed Sponsors

lead

Endeavor Health

OTHER

NCT03697720 - Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain | Biotech Hunter | Biotech Hunter